Guidelines for ATC classification and DDD assignment ... - WHOCC

More documents

Recommendations

Info

A08A09A10A11A12A13A14A15A16ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTSA Antiobesity preparations, excl. diet productsDIGESTIVES, INCL. ENZYMESA Digestives, incl. enzymesDRUGS USED IN DIABETESA Insulins and analoguesB Blood glucose lowering drugs, excl. insulinsX Other drugs used in diabetesVITAMINSA Multivitamins, combinationsB Multivitamins, plainC Vitamin A and D, incl. combinations of the twoD Vitamin B 1 , plain and in combination with vitamin B 6 and B 12E Vitamin B-complex, incl. combinationsG Ascorbic acid (vitamin C), incl. combinationsH Other plain vitamin preparationsJ Other vitamin products, combinationsMINERAL SUPPLEMENTSA CalciumB PotassiumC Other mineral supplementsTONICSA TonicsANABOLIC AGENTS FOR SYSTEMIC USEA Anabolic steroidsB Other anabolic agentsAPPETITE STIMULANTSOTHER ALIMENTARY TRACT AND METABOLISM PRODUCTSA Other alimentary tract and metabolism products50
AA01A01AALIMENTARY TRACT AND METABOLISMSTOMATOLOGICAL PREPARATIONSSTOMATOLOGICAL PREPARATIONSThis group comprises agents for treatment of conditions of mouth andteeth. It is difficult to differentiate between preparations for use in themouth and preparations for use in the throat. Preparations mainly usedin gingivitis, stomatitis etc. should be classified in this group.Preparations for the treatment of throat infections, (lozenges forcommon cold conditions) are classified in R02 - Throat preparations.Preparations containing local anesthetics, see N01B - Anesthetics, local,and R02AD - Anesthetics, local.A01AACaries prophylactic agentsThis group comprises all types of fluoride preparations (tablets, gargles,toothpastes, chewing-gum etc.).Combinations of olaflur and dectaflur are classified at the 5th level ofolaflur - A01AA03. Combinations of sodium fluoride and sodiummonofluorophosphate are classified in A01AA30.For caries prophylactic agents in A01AA, the DDDs are based onuse in children. DDDs are only established for tablets.A01ABAntiinfectives and antiseptics for local oral treatmentThis group comprises all antiinfective and antiseptic agents for thetreatment of stomatitis, gingivitis etc. Products used in common minorinfections of mouth and throat are classified in R02, e.g. cetylpyridinium.Other antibiotics for local use, see D - Dermatologicals.The DDD for amphotericin in this group refers to lozenges.The DDD for minocycline is based on the amount of activesubstance used in one periodontal pocket in local treatment ofperiodontitis.51
Page 1 and 2: Guidelines forATC classificationand
Page 3 and 4: Guidelines forATC classificationand
Page 5 and 6: PREFACEThe Anatomical Therapeutic C
Page 7: TABLE OF CONTENTSI. Introduction ..
Page 11 and 12: B. Present Organisational responsib
Page 13 and 14: - To develop methods, manuals and g
Page 15 and 16: II.THE ANATOMICAL THERAPEUTIC CHEMI
Page 17 and 18: Two examples of this are as follows
Page 19 and 20: Plain products are classified accor
Page 21 and 22: Alterations in ATC classification c
Page 23 and 24: DDDs are not established for topica
Page 25 and 26: 2. Combination productsThe DDDs ass
Page 27 and 28: d) Duration of treatmentThe duratio
Page 29 and 30: D. Principles for reviewing and cha
Page 31 and 32: Prescribed daily doseThe prescribed
Page 33 and 34: A. Drug utilizationThe ATC/DDD syst
Page 35 and 36: Since alterations of ATC and DDDs d
Page 37 and 38: F. Drug costs, pricing and reimburs
Page 39 and 40: It is left to the national users of
Page 41 and 42: Useful sources of these data would
Page 43 and 44: A DDD will only be assigned for sub
Page 45 and 46: - a change in the main indication s
Page 47 and 48: VIII. ATC/DDD INTERPRETATIVE GUIDEL
Page 49: AALIMENTARY TRACT AND METABOLISMA01
Page 53 and 54: Plain antiflatulents, see A03AX - O
Page 55 and 56: A02BBA02BCProstaglandinsProton pump
Page 57 and 58: A03ADPapaverine and derivativesComb
Page 59 and 60: Opioid analgesics in combination wi
Page 61 and 62: Droperidol used for prevention of n
Page 63 and 64: Combinations with osmotically actin
Page 65 and 66: A07AAAntibioticsVancomycin and coli
Page 67 and 68: A07EA07EAINTESTINAL ANTIINFLAMMATOR
Page 69 and 70: DDDs can be difficult to establish
Page 71 and 72: A10XA10XAOTHER DRUGS USED IN DIABET
Page 73 and 74: A11AA03multivitamins and other mine
Page 75 and 76: For vitamin B 1 in combination with
Page 77 and 78: A12AX - Calcium, combinations with
Page 79 and 80: See also:A11AA02 - multivitamins an
Page 81 and 82: A13A13ATONICSTONICSThis group compr
Page 83 and 84: BBLOOD AND BLOOD FORMING ORGANSB01B
Page 85 and 86: Lysine acetylsalicylate is classifi
Page 87 and 88: ased adhesives, are classified in V
Page 89 and 90: B03AEIron in other combinationsThis
Page 91 and 92: B05BLOOD SUBSTITUTES AND PERFUSION
Page 93 and 94: B05XAElectrolyte solutionsThis grou
Page 95 and 96: CCARDIOVASCULAR SYSTEMC01C02C03C04C
Page 97 and 98: CC01C01ACARDIOVASCULAR SYSTEMCARDIA
Page 99 and 100: C01CCARDIAC STIMULANTS EXCL. CARDIA
Page 101 and 102:
C01EOTHER CARDIAC PREPARATIONSThis
Page 103 and 104:
Combinations with other antihyperte
Page 105 and 106:
C02DDC02DGNitroferricyanide derivat
Page 107 and 108:
C02LNC02LXC02NSerotonin antagonists
Page 109 and 110:
C03BBSulfonamides and potassium in
Page 111 and 112:
C04ACNicotinic acid and derivatives
Page 113 and 114:
C05BAHeparins or heparinoids for to
Page 115 and 116:
C07BGAlpha and beta blocking agents
Page 117 and 118:
Combinations with ACE inhibitors ar
Page 119 and 120:
C09BBACE inhibitors and calcium cha
Page 121:
C10BLIPID MODIFYING AGENTS, COMBINA
Page 124 and 125:
D10D11ANTI-ACNE PREPARATIONSA Anti-
Page 126 and 127:
D01ACImidazole and triazole derivat
Page 128 and 129:
D02AXOther emollients and protectiv
Page 130 and 131:
D04ABAnesthetics for topical useAt
Page 132 and 133:
D06AATetracycline and derivativesCo
Page 134 and 135:
The group is subdivided according t
Page 136 and 137:
D08ABAluminium agentsCombinations w
Page 138 and 139:
D10AACorticosteroids, combinations
Page 140 and 141:
D11AXOther dermatologicalsThis grou
Page 142 and 143:
GG01GENITO URINARY SYSTEM AND SEX H
Page 144 and 145:
G02OTHER GYNECOLOGICALSAnalgesics u
Page 146 and 147:
G02CCAntiinflammatory products for
Page 148 and 149:
G03ADEmergency contraceptivesLevono
Page 150 and 151:
G03CXOther estrogensTibolone is cla
Page 152 and 153:
package which is intended for one c
Page 154 and 155:
G04BCUrinary concrement solventsThi
Page 157 and 158:
HSYSTEMIC HORMONAL PREPARATIONS, EX
Page 159 and 160:
The DDDs are based on the treatment
Page 161 and 162:
H02ACORTICOSTEROIDS FOR SYSTEMIC US
Page 163 and 164:
H04H04AH04AAPANCREATIC HORMONESGLYC
Page 165 and 166:
JANTIINFECTIVES FOR SYSTEMIC USEJ01
Page 167 and 168:
J01ANTIBACTERIALS FOR SYSTEMIC USET
Page 169 and 170:
inhibitor are classified at a separ
Page 171 and 172:
The DDDs for the sulfonamides are r
Page 173 and 174:
The DDDs for the aminoglycosides ar
Page 175 and 176:
J01XXOther antibacterialsPreparatio
Page 177 and 178:
J04ADJ04AKJ04AMThiocarbamide deriva
Page 179 and 180:
J05AGNon-nucleoside reverse transcr
Page 181 and 182:
J07AGHemophilus influenzae B vaccin
Page 183:
J07BFPoliomyelitis vaccinesPoliomye
Page 186 and 187:
LANTINEOPLASTIC AND IMMUNOMODULATIN
Page 188 and 189:
L01DBL01DCAnthracyclines and relate
Page 190 and 191:
L02BXOther hormone antagonists and
Page 192 and 193:
L04ACL04ADL04AXInterleukin inhibito
Page 194 and 195:
MM01M01AMUSCULO-SKELETAL SYSTEMANTI
Page 196 and 197:
The DDD for glucosamine refers to g
Page 198 and 199:
Combined preparations containing no
Page 200 and 201:
M03CMUSCLE RELAXANTS, DIRECTLY ACTI
Page 202 and 203:
M05BXOther drugs affecting bone str
Page 204 and 205:
NN01NERVOUS SYSTEMANESTHETICSNo DDD
Page 206 and 207:
N01BCN01BXEsters of benzoic acidOth
Page 208 and 209:
The DDDs are based on approved dose
Page 210 and 211:
This means that a product containin
Page 212 and 213:
Antivertigo preparations, see N07.C
Page 214 and 215:
All other benzodiazepines are class
Page 216 and 217:
N05AANTIPSYCHOTICSThis group compri
Page 218 and 219:
The parenteral DDD for chlordiazepo
Page 220 and 221:
N05CFN05CHBenzodiazepine related dr
Page 222 and 223:
N06BXOther psychostimulants and noo
Page 224 and 225:
N07BCDrugs used in opioid dependenc
Page 226 and 227:
PANTIPARASITIC PRODUCTS, INSECTICID
Page 228 and 229:
P01BCMethanolquinolinesCombined pre
Page 230 and 231:
P02ANTHELMINTICSThe anthelmintics a
Page 232 and 233:
P03AECTOPARASITICIDES, INCL. SCABIC
Page 234 and 235:
RRESPIRATORY SYSTEMInhaled antiinfe
Page 236 and 237:
R01BNASAL DECONGESTANTS FOR SYSTEMI
Page 238 and 239:
The DDDs for inhalation aerosol and
Page 240 and 241:
R03BXOther drugs for obstructive ai
Page 242 and 243:
Fixed DDDs are assigned for combina
Page 244 and 245:
R05XOTHER COLD PREPARATIONSThis gro
Page 246 and 247:
R07AALung surfactantsThis group com
Page 248 and 249:
SSENSORY ORGANSA formulation approv
Page 250 and 251:
S01CBCorticosteroids/antiinfectives
Page 252 and 253:
S01GXOther antiallergicsCombination
Page 254 and 255:
S02OTOLOGICALSSmall amounts of anti
Page 256 and 257:
S03AS03AAANTIINFECTIVESAntiinfectiv
Page 258 and 259:
V10V20THERAPEUTIC RADIOPHARMACEUTIC
Page 260 and 261:
Silibinin, which is also used in am
Page 262 and 263:
V04V04BDIAGNOSTIC AGENTSURINE TESTS
Page 264 and 265:
V06DXOther combinations of nutrient
Page 266 and 267:
V08BV08BAX-RAY CONTRAST MEDIA, NON-
Page 268 and 269:
V09E - Respiratory system.Technetiu
Page 270 and 271:
V09HINFLAMMATION AND INFECTION DETE
Page 272 and 273:
Iobenguane ( 131 I) in low dose for
Page 274 and 275:
DDDs per 100 bed days Applied when
Page 276 and 277:
276
Page 279 and 280:
WHO COLLABORATING CENTRE FORDRUG ST
Page 281:
ANNEX II
Page 284:
ORDER FORM - ATC/DDD PUBLICATIONSPa
show all

Guidelines for ATC classification and DDD assignment ... - WHOCC

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?